Delivery Order SPE2DB22D3010-SPE2DB25FP3HQ
- Not listed
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.95 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution in 2ML units. This firm fixed price delivery order, awarded on August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside provisions and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for VEVYE 0.1% eye drop medication in a 2ML quantity, valued at $2,124.20. This is a firm fixed price delivery order with no set-aside designation, employing competitive procurement procedures. The order is scheduled for ultimate completion on August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This delivery order, valued at $3,143.94, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vevye 0.1% eye drops in 2ML units to support federal medical procurement needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA). The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25,...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3HQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,571.97 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop in 2ML units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with DLA, supplying everything from specialty medications and vaccines to medical devices across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/27/25 |